Pre-Industrial Clinical Trials
Regulatory-grade preclinical and product-readiness studies provide the safety and efficacy evidence a candidate needs before human trials or market scale-up.
This division conducts the studies that turn a promising candidate into a documented, defensible product. We test drugs, vaccines, herbal formulations and industrial compounds in validated animal models, generating data that regulators and partners can trust.
Every study is designed with the end submission in mind. Protocols follow internationally recognized guidelines such as OECD Test Guideline 407 for repeated-dose oral toxicity with proper controls, GLP-aligned conduct and statistical analysis, so the resulting evidence stands up to review by the National Drug Authority and international bodies.
What this division does
01
Toxicology & Safety Studies
Acute, sub-acute, sub-chronic and chronic toxicity testing with full histopathology, clinical chemistry and NOAEL determination.
02
Efficacy & Proof-of-Concept
Disease-model studies showing whether a candidate produces its intended biological effect before clinical investment.
03
Pharmacokinetics & Pharmacodynamics
ADME profiling and dose-response characterisation to inform safe first-in-human dosing.
04
Herbal & Natural Product Testing
Safety and quality evaluation of locally developed herbal products, supporting NDA submissions.
05
Regulatory & Submission Support
Study designs and dossiers structured for Uganda’s UNCST/NDA pathway and international requirements.
WHO THIS DIVISION SERVES
- ›Pharmaceutical developers
- ›Herbal & natural product manufacturers
- ›Agro-industrial & chemical firms
- ›Academic research groups
WORK WITH THIS DIVISION
Discuss your requirements and get a scoped, costed proposal.
Pre-Industrial Clinical Trials — let’s talk specifics.
Regulatory-grade pre-clinical and product-readiness studies that generate the safety and efficacy evidence a candidate needs before human trials or market scale-up.